XML 93 R82.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES (Fair Value Contingent Consideration) (Details) - Contingent Consideration Liability - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, beginning of period $ 69,657 $ 87,312
Payment (5,000) 0
Change in fair value of contingent consideration liabilities (162) 456
Balance, end of period 64,495 87,768
Arkis | Level 3    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, beginning of period 12,968 15,755
Payment (5,000)  
Change in fair value of contingent consideration liabilities (812) (83)
Balance, end of period 7,156 15,672
Arkis | Level 3 | Short-Term - Accrued expenses and other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period 3,598 7,562
Arkis | Level 3 | Long-Term - Other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period 3,558 8,110
Derma Sciences | Level 3    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, beginning of period 2,686 2,557
Payment 0  
Change in fair value of contingent consideration liabilities 50 39
Balance, end of period 2,736 2,596
Derma Sciences | Level 3 | Short-Term - Accrued expenses and other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period 0 0
Derma Sciences | Level 3 | Long-Term - Other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period 2,736 2,596
ACell | Level 3    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, beginning of period 3 300
Payment 0  
Change in fair value of contingent consideration liabilities 0 0
Balance, end of period 3 300
ACell | Level 3 | Short-Term - Accrued expenses and other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period 0 0
ACell | Level 3 | Long-Term - Other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period 3 300
Surgical Innovation Associates, Inc. | Level 3    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, beginning of period 54,000 68,700
Payment 0  
Change in fair value of contingent consideration liabilities 600 500
Balance, end of period 54,600 69,200
Surgical Innovation Associates, Inc. | Level 3 | Short-Term - Accrued expenses and other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period 35,000 29,300
Surgical Innovation Associates, Inc. | Level 3 | Long-Term - Other liabilities    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance, end of period $ 19,600 $ 39,900